Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00653263 · ClinicalTrials.gov registry record
Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
A clinical trial of Methamphetamine-dependence and Methamphetamine Withdrawal, sponsored by University of Arkansas.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT00653263: Completed study of Methamphetamine-dependence and Methamphetamine Withdrawal, sponsored by University of Arkansas.
NCT00653263 is a study of Methamphetamine-dependence and Methamphetamine Withdrawal that has completed, run by University of Arkansas. The registered enrollment target is 8 participants, below the 106-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00653263, a study of Methamphetamine-dependence and Methamphetamine Withdrawal, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Methamphetamine use has escalated in recent years. Methamphetamine use has also spread throughout the country. Although much information has been gathered on the treatment of cocaine abuse, very little information has been obtained on the treatment of methamphetamine abuse. One of the first steps in developing appropriate treatment is to examine the effects of stopping a particular substance's use on individuals abusing that substance. To date this has not been well studied for people abusing methamphetamine. The purpose of this study is to better understand and develop accurate ways of measuring symptoms associated with stopping the use of methamphetamine in people that are abusing methamphetamine. If the withdrawal symptoms are able to be effectively measured, this will help to develop treatments targeted at alleviating these symptoms. These symptoms are often associated with relapse to use of that substance.
Primary Outcome
Methamphetamine Selective Severity Assessment (MSSA) is an 18 item questionnaire assessing withdrawal symptoms with each question measured on a scale from 0(best score)-7(worst score) for a range in scores from 0(best score)-126(worst score). Higher scores indicate more severe withdrawal symptoms.
Conditions Studied
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-08 |
What the finished NCT00653263 record still lists
NCT00653263 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 106-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Methamphetamine-dependence appearing as the primary indexed condition, and to 0 interventions.
NCT00653263 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00653263 about?
NCT00653263 is a clinical study titled "Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study". Methamphetamine use has escalated in recent years. Methamphetamine use has also spread throughout the country. Although much information has been gathered on the treatment of cocaine abuse, very little information has been obtained on the treatment of methamphetamine abuse. One of the first steps in...
What is the current status of trial NCT00653263?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2006-08. Estimated completion is 2008-08.
What conditions does trial NCT00653263 study?
This clinical trial studies the following conditions: Methamphetamine-dependence, Methamphetamine Withdrawal.
Who is sponsoring clinical trial NCT00653263?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00653263 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine-dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00653263's enrollment target sits among peer trials
8 19th of 18 the lowest of 18 other Methamphetamine-dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Methamphetamine-dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
RECRUITING · Phase 3
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
-
PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)
RECRUITING · Early Phase 1
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia